World's Best Scientists 2026 revealed!
Neuropharmacology
H-index 52

Neuropharmacology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Neuroscience 35 476 540 45
Medicine 454 196 240 37

Additional Metrics

Number of Best Scientists*: 835
Documents by Best Scientists*: 802
Top 100 Ranked Scientists*: 23
SCIMAGO H-index: 199
SCIMAGO SJR: 1.589
Impact Factor: 4.6

Overview

Top Research Topics at Neuropharmacology?

Neuropharmacology is mainly concerned with subjects like Internal medicine, Endocrinology, Pharmacology, Neuroscience and Receptor. Neuropharmacology covers various topics on Internal medicine such as 5-HT receptor, Receptor antagonist, Hypothalamus, Central nervous system and Acetylcholine. In Neuropharmacology, Agonist and Serotonin are investigated in conjunction with one another to address concerns in Endocrinology research.

Topics in Pharmacology explored in the journal were investigated in conjunction with research in Anesthesia, Antagonist and GABAA receptor. While Neuroscience is the focus of the journal, it also provided insights into the studies of Glutamate receptor, NMDA receptor and Neurotransmission. The work on Glutamate receptor presented in the journal focuses on Metabotropic glutamate receptor in particular.

AMPA receptor is a major topic of NMDA receptor research. The study of Biochemistry serves as the foundation of the Receptor research discussed in the journal. Research on Biochemistry addressed in Neuropharmacology frequently intersections with the field of Biophysics.

  • Internal medicine (39.19%)
  • Endocrinology (39.04%)
  • Pharmacology (34.36%)

What are the most cited papers published in the journal?

  • A review of central 5-HT receptors and their function (2744 citations)
  • The metabotropic glutamate receptors: structure and functions. (2140 citations)
  • Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine (1179 citations)

Research areas of the most cited articles at Neuropharmacology:

The journal papers focus on Pharmacology, Internal medicine, Endocrinology, Neuroscience and Receptor. While Internal medicine is the focus of the published articles, it also provides insights into the studies of Antidepressant and Mechanism of action. The studies on Endocrinology discussed at the journal publications can also contribute to research in the domains of Receptor antagonist and 5-HT receptor, Serotonin.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Enzyme

The previous edition focused in particular on these issues:

The journal mainly tackles studies in Neuroscience, Pharmacology, Receptor, Internal medicine and Endocrinology. Issues in Neuroscience were discussed, taking into consideration concepts from other disciplines like Glutamate receptor, NMDA receptor, Neurotransmission and Synaptic plasticity. The research on Pharmacology featured in Neuropharmacology combines topics in other fields like Agonist, Dopamine, Cannabinoid and Antagonist.

Receptor research featured in it incorporates concerns from various other topics such as Ethanol and Cell biology. The Internal medicine works, particularly on Hippocampus are tackled in Neuropharmacology. Topics like Basolateral amygdala and Striatum are tackled as part of the discussions on Endocrinology.

The most cited articles from the last journal are:

  • Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease. (17 citations)
  • Sex differences in vulnerability to addiction (9 citations)
  • Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research. (9 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Neuropharmacology (based on the number of publications) are:

  • Graham L. Collingridge (58 papers) published 3 papers at the last edition,
  • Ferdinando Nicoletti (43 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Robert J. Naylor (43 papers) absent at the last edition,
  • Brenda Costall (40 papers) absent at the last edition,
  • Charles A. Marsden (39 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Neuropharmacology (based on the number of publications) are:

  • National Institutes of Health (249 papers) published 4 papers at the last edition the same number as at the previous edition,
  • French Institute of Health and Medical Research (185 papers) published 5 papers at the last edition, 2 less than at the previous edition,
  • University of Bristol (172 papers) published 10 papers at the last edition, 9 more than at the previous edition,
  • Centre national de la recherche scientifique (153 papers) published 6 papers at the last edition, 3 less than at the previous edition,
  • Eli Lilly and Company (152 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.06% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 10.24% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.53% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.07% of all publications and 64.16% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career in Neuropharmacology

Although the career paths in the field of Neuropharmacology are diverse, a popular route is the Speech-Language Pathologist, often centered in research and treatment of neurologically-impaired patients. The roles and requirements for becoming a Speech-Language Pathologist can vary from state to state. For instance, the set of skills, education, and certifications required can differ for professionals practicing in Oregon.

If you would like to explore the path of becoming a Speech-Language Pathologist in Oregon, the following article titled 'speech pathologist requirements in oregon' provides an in-depth guide.

In general, those drawn to Neuropharmacology can enjoy challenging and rewarding careers. They can make a substantial impact on the quality of patients' lives and significantly advance our understanding of the brain and its functionalities.

Top Publications

  • Mechanisms of action of currently used antiseizure drugs.

    Graeme J. Sills;Michael A. Rogawski

    (2020)
    440 Citations
  • Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration

    Jens V. Andersen;Kia H. Markussen;Emil Jakobsen;Arne Schousboe

    (2021)
    343 Citations
  • Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology.

    Stephen John Kaar;Sridhar Natesan;Robert McCutcheon;Oliver D. Howes

    (2020)
    275 Citations
  • Inflammation and reactive oxygen species as disease modifiers in epilepsy.

    Gaetano Terrone;Silvia Balosso;Alberto Pauletti;Teresa Ravizza

    (2020)
    182 Citations
  • Amygdala, neuropeptides, and chronic pain-related affective behaviors.

    Volker Neugebauer;Mariacristina Mazzitelli;Bryce Cragg;Guangchen Ji

    (2020)
    142 Citations
  • Central 5-HT receptors and their function; present and future.

    Trevor Sharp;Nicholas M Barnes

    (2020)
    138 Citations
  • The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments.

    Wolfgang Löscher

    (2020)
    136 Citations

Related Online Degrees & Career Pathways

For students interested in Medicine in the USA, exploring related online degrees can open diverse career pathways in healthcare. Beyond traditional medical degrees, programs in healthcare administration, nursing, and advanced practice offer flexible options to build a strong professional foundation.

Understanding the healthcare administration degree cost is crucial for those looking to manage healthcare facilities or work in health system leadership. These programs often provide valuable skills in finance, management, and policy.

For clinical roles, pursuing online nursing degrees is a popular choice. Many wonder how much is online nursing school, and finding affordable options can make advancing in this caring profession more accessible.

Nurses seeking advanced clinical practice might consider enrolling in online fnp programs, which prepare family nurse practitioners to provide comprehensive healthcare in diverse settings.

Likewise, for those aiming for the highest level of nursing education, the cheapest dnp programs online offer pathways to develop leadership skills and clinical expertise at the doctoral level.

Considering these related degrees alongside Medicine can broaden career opportunities and empower students to find roles that fit their goals and circumstances.

Best Scientists Contributing to This Journal

Recently Published Articles